Abstract
RATIONALE
Primary signet ring cell carcinoma of the uterine cervix is extremely rare and the clinical characteristics and prognosis are not well known and there are no specific guidelines for treatment.
PATIENT CONCERNS
A 43-year-old woman was referred to our hospital for abnormal uterine bleeding lasting 1 month.
DIAGNOSES
Histological examination revealed a signet ring cell carcinoma of the uterine cervix. After evaluation of extragenital origin, the patient was diagnosed International Federation of Gynecology and Obstetrics stage IIIC1 primary signet ring cell carcinoma or the uterine cervix.
INTERVENTION
The patient was prescribed concomitant chemo-radiation followed by intracavitary brachytherapy.
OUTCOMES
She showed no evidence of disease after treatment but, it recurred after 7 months of last treatment.
LESSONS
Different approaches to diagnosis and treatment of this rare disease are needed and molecular pathological studies related to the onset of the disease are required.
Collapse